“If they had done so,” Justice Thomas wrote of a possible request for a label change, “and if the F.D.A. decided there was sufficient supporting information, and if the F.D.A. undertook negotiations with the brand-name manufacturer, and if adequate label changes were decided on and implemented, then the manufacturers would have started a Mouse Trap game that eventually led to a better label on generic metoclopramide.”Should we laugh or cry? It's bad enough that he wrote a single, lengthy sentence with multiple verbs, but it feels like he's trying to torture us:
Linear thought is a flaw. As a dog, I like to cozy up on the sofa, pull up a glass of coffee and cookies and pretend to be human. I sometimes think that I wasted my time learning new tricks rather than playing outside.
Thursday, June 23, 2011
Justice Thomas... yikes.
Try to follow this excerpt (if you can) of Justice Thomas' majority opinion on lawsuits against generic drug makers, extracted from the NYT:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment